Interleukin-17 Produced by Malignant Mesothelioma-Polarized Immune Cells Promotes Tumor Growth and Invasiveness
Malignant mesothelioma (MM) is a highly fatal tumor of inner body membranes, the extensive growth of which is supported by both a weak immunogenicity and the ability to reprogram surrounding immune cells towards tumor-supporting phenotypes. Interleukin-17 (IL-17) is a major inflammatory cytokine whi...
Main Authors: | V. Izzi, V. Chiurchiù, E. Doldo, C. Palumbo, I. Tresoldi, R. Bei, L. Albonici, A. Modesti |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-01-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/1721727X1301100119 |
Similar Items
-
Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
by: Eiji Takeuchi, et al.
Published: (2020-10-01) -
In Vitro and In Vivo Anti-tumoral Effects of the Flavonoid Apigenin in Malignant Mesothelioma
by: Laura Masuelli, et al.
Published: (2017-06-01) -
Role of interleukin-6 (IL-6) in diagnosis of malignant pleural mesothelioma
by: Rehab El Sayed, et al.
Published: (2015-04-01) -
Malignant Mesothelioma
by: Phunchai Charuscharoenwitthaya, et al.
Published: (2002-09-01) -
Malignant mesothelioma
by: Parker Robert J, et al.
Published: (2008-12-01)